Vyteris, Inc. (VYTR.OB) Announces Balance Sheet Restructuring
Vyteris Inc. is a leader in active transdermal drug delivery technology. The company is the maker of the first active, ready-to-use drug delivery patch – LidoSite – to receive marketing clearance from the US Food and Drug Administration (FDA). The company's proprietary active transdermal patch technology delivers drugs comfortably through the skin using low-level electrical energy. This smart patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic advantages over existing methods of drug delivery. Vyteris announced today the sale of $2.3 million of net…